Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Immunisation, Inflammatory marker increased, Lymphadenopathy, Rash
Clinical narrative: booster; My blood work from mid early November showed inflammatory markers and high CRP levels.; inflammation all around my collarbone and neck area; enlarged lymph nodes above my collarbone; Ive also had a patchy red rash on my legs and lower stomach.; I have felt exteme fatigue in my arms and shoulders; My blood work from mid early November showed inflammatory markers and high CRP levels.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Sep2021 12:00 (Lot number: EW0167) at the age of 37 years as dose 3 (booster) , single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6198, Location of injection: Arm Left, Time: 12:00 PM), administration date: 26Feb2021, when the patient was 37 years old, for COVID-19 Immunization, reaction(s): "no reactions"; Bnt162b2 (Dose Number: 1, Batch/Lot No: EM9810, Location of injection: Arm Left, Time: 12:00 PM), administration date: 03Feb2021, when the patient was 37 years old, for Covid-19 immunization, reaction(s): "no reactions". The following information was reported: IMMUNISATION (non-serious) with onset 04Oct2021, outcome "not recovered", described as "booster"; C-REACTIVE PROTEIN INCREASED (non-serious), INFLAMMATORY MARKER INCREASED (non-serious) all with onset 04Oct2021, outcome "not recovered" and all described as "My blood work from mid early November showed inflammatory markers and high CRP levels."; DERMATITIS (non-serious) with onset 04Oct2021, outcome "not recovered", described as "inflammation all around my collarbone and neck area"; LYMPHADENOPATHY (non-serious) with onset 04Oct2021, outcome "not recovered", described as "enlarged lymph nodes above my collarbone"; RASH (non-serious) with onset 04Oct2021, outcome "not recovered", described as "Ive also had a patchy red rash on my legs and lower stomach."; FATIGUE (non-serious) with onset 04Oct2021, outcome "not recovered", described as "I have felt exteme fatigue in my arms and shoulders". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of immunisation, c-reactive protein increased, dermatitis, lymphadenopathy, fatigue, inflammatory marker increased. Therapeutic measures were taken as a result of rash.  Additional information: Adverse event: With the first two shots, patient had no reactions. Ever since the 3rd shot, she has had inflammation all around collarbone and neck area and enlarged lymph nodes above collarbone. She also had a patchy red rash on legs and lower stomach. Patient felt extreme fatigue in arms and shoulders. She went to the dermatologist for the rash, and they prescribed her a steroid that made the rash go away. Ever since the steroid ended the rash has reappeared. She has contacted her PCP which has sent her to a cardiologist. She had an EKG which was normal, but my stress test showed to be a little concerning. They have her scheduled for an Echo and 48-hour monitor in mid-December. My blood work from mid early November showed inflammatory markers and high CRP levels. She will be going back on 08Dec2021 to the dermatologist to get a skin biopsy of my rash. Patient did not receive any other vaccine in four weeks. Prior to vaccination, patient did not have covid. No allergies were reported. Other medications in two weeks included LE-VEL THRIVE VITAMINS.  No follow-up attempts are possible. No further information is expected.